Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy

This publication has 14 references indexed in Scilit:

• Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2–3 N0 M0 prostatic carcinoma
  Urology, 1997
• Effect of Neoadjuvant Endocrine Therapy (Combined Androgen Blockade) on Normal Prostate and Prostatic Carcinoma
  The American Journal of Surgical Pathology, 1996
• Prognostic Significance of Positive Surgical Margins in Radical Prostatectomy Specimens
  Journal of Urology, 1995
• Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer
  Journal of Urology, 1995
• Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients
  Cancer, 1995
• Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist
  Urology, 1994
• Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic Adenocarcinoma
  The American Journal of Surgical Pathology, 1994
• Is Tumor Volume an Independent Predictor of Progression Following Radical Prostatectomy? A Multivariate Analysis of 185 Clinical Stage B Adenocarcinomas of the Prostate with 5 Years of Followup
  Journal of Urology, 1993
• Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide
  Urology, 1992
• Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic Adenocarcinoma
  The American Journal of Surgical Pathology, 1991